Direct Oral Anticoagulants for the Treatment of Unusual-Site Venous Thrombosis: An Update
Pharmaceutics · 07.03.2025 · 17 (3) · 342
DOI: 10.3390/pharmaceutics17030342 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 07.03.2025. Verfasst von Anabel Franco-Moreno und 4 weiteren Autor:innen. Beteiligte Einrichtung: Venous Thromboembolism Unit, Department of Internal Medicine, Hospital Universitario Infanta Leonor, Avenida Gran Via del Este, 80, 28031 Madrid, Spa…. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Direct oral anticoagulants (DOACs) have emerged as the preferred oral anticoagulant therapy for patients with deep vein thrombosis of the lower extremities and pulmonary embolism. DOACs offer several advantages over vitamin K antagonists, including fixed dosage, fewer drug interactions, faster onset of action, and a lower risk of major bleeding, especially intracranial. Although evidence on the use of DOACs in unusual-site venous thrombosis (USVT) is limited, their use in such cases is becoming increasingly common. This narrative review examines the evidence derived from randomized controlled trials, and large observational studies focused on the use of the DOACs in USVT, including cerebral, splanchnic, upper extremity, ovarian, renal, and retinal vein thrombosis. In addition, it also provides practical advice for their use in these clinical settings according to the updated scientific literature.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Venous Thromboembolism Unit, Department of Internal Medicine, Hospital Universitario Infanta Leonor, Avenida Gran Via del Este, 80, 28031 Madrid, Spain.
- Venous Thromboembolism Unit, Department of Internal Medicine, Hospital Universitario de Fuenlabrada, Camino del Molino, 2, Fuenlabrada, 28942 Madrid, Spain.
- Hospital Universitario Gregorio Marañón, Calle del Dr. Esquerdo, 46, 28007 Madrid, Spain.
- Venous Thromboembolism Unit, Hospital Universitario de Torrejón, Calle Mateo Inurria, Torrejón de Ardoz, 28850 Madrid, Spain.
ORCID-Profile: Anabel Franco-Moreno
Zitieren
APA
Franco-Moreno, A., Madroñal-Cerezo, E., Martínez-Casa-Muñoz, A., Ortiz-Sánchez, J., & Ancos-Aracil, C. L. (2025). Direct Oral Anticoagulants for the Treatment of Unusual-Site Venous Thrombosis: An Update. Pharmaceutics, 17(3), 342. https://doi.org/10.3390/pharmaceutics17030342
Vancouver
Franco-Moreno A, Madroñal-Cerezo E, Martínez-Casa-Muñoz A, Ortiz-Sánchez J, Ancos-Aracil CL. Direct Oral Anticoagulants for the Treatment of Unusual-Site Venous Thrombosis: An Update. Pharmaceutics. 2025;17(3):342. doi:10.3390/pharmaceutics17030342
BibTeX
@article{FrancoMoreno2025,
author = {Franco-Moreno, Anabel and Madroñal-Cerezo, Elena and Martínez-Casa-Muñoz, Ana and Ortiz-Sánchez, Judith and Ancos-Aracil, Cristina Lucía},
title = {Direct Oral Anticoagulants for the Treatment of Unusual-Site Venous Thrombosis: An Update},
journal = {Pharmaceutics},
year = {2025},
volume = {17},
number = {3},
pages = {342},
doi = {10.3390/pharmaceutics17030342}
}
EUVIMED